482 GRL-142, a Novel HIV-1 Protease Inhibitor, Potently Blocks HIV-1 Ex Vivo Infection of Langerhans Cells Within Epithelium
Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.558
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2019
Authors
Publisher
Elsevier BV